WillItSurvive

Efort Intelligent Equipment

Chinese maker of industrial robot arms and factory automation systems, listed in Shanghai.

Little protection left
Assessed 30 July 2026 · Evidence as of 30 July 2026
Not much stands between this business and its pressures.
On the recordSince 30 July 2026 · Checkable from July 29, 2026 · Every call on the record Checkpoint: US ban on Chinese humanoid robot imports takes effect
The call

A subscale Chinese robot-arm maker with two years of revenue decline, a big new factory to fill, and a humanoid pivot that hasn't shipped yet.

Efort makes industrial robot arms for factories in China, but its sales have been cut in half over two years and it is losing money. It is hard for Efort to stand out because bigger Chinese companies like Estun and global giants like FANUC already own most of the market, and new AI software from NVIDIA and smaller robot companies from other countries are making custom robot work cheaper and easier to copy. The one thing that matters: whether the new factory Efort is building actually brings in enough new business to stop the decline, or if sales keep falling and the company runs out of cash.

Why
01
AI pressure: NVIDIA Isaac GR00T foundation models and generalist humanoid makers (Unitree, AgiBot, Boston Dynamics). Foundation-model humanoids threaten to commoditize the custom arm-integration work EFORT sells, while its own Openmind models remain unshipped. Could AI do the core job? Yes, likely.
02
Bigger players: Estun Automation, plus FANUC, ABB, and KUKA. Estun leads China's robot-arm market and just raised fresh capital on a March 2026 Hong Kong listing while EFORT's revenue keeps shrinking. Could a giant copy it? Yes, easily.
03
What protects it. Exports are 44% of 2024 revenue, the highest ratio among major Chinese robot makers, giving it a channel rivals focused on China don't have.
What would change this call
EFORT reports Q2/Q3 2026 revenue growth or reversion to decline. Shows whether Q1's +20.5% was a real turnaround or a low-base blip.
Openmind's R2V1/R2V2/W2 models get paid customer deployments, not just announcements. Would show the AI/humanoid pivot has actual commercial traction.
Estun's post-listing capital spend and China market share moves after March 2026 HK IPO. Indicates whether the domestic leader is pulling further ahead of EFORT.
Key numbers
  • FY2025 revenue CNY 932.13m, down 32.1% YoY (2025-12-31)
  • TTM net loss about CNY 439.52m (2026-07-09)
  • Q1 2026 revenue CNY 304.13m, up 20.55% YoY (2026-03-31)
Named risks
  • Revenue collapsed from CNY 1.89bn (2023) to CNY 932m (2025), roughly 50% in two years. Severity: high
  • Persistent net losses, TTM loss of CNY 439.52m as of July 2026. Severity: high
  • US FCC ban on Chinese humanoid robot imports, effective July 29, 2026, blocks a US path for Openmind. Severity: medium
  • Building CNY 1.9bn super-factory while Estun secures fresh HK-listing capital, widening the funding gap. Severity: medium
  • Openmind's embodied-AI models (R2V1, R2V2, W2) have no independently verified commercial shipments. Severity: medium
Rivals, as read in July 2026
RivalDirectionEvidence
Estun Automationgaining onCompleted HK listing March 2026 raising fresh capital while EFORT revenue fell 32.1% in FY2025
Siasun Robot & Automationlosing toSiasun market cap ~CNY 26.4bn (Aug 2025) dwarfs EFORT's ~CNY 7.9bn (Jul 2026)
FANUCcontestingHolds ~10.9% China market share as of Feb 2026, competing directly in EFORT's core arm segment
NVIDIA GR00T-powered humanoid makers (Unitree, Boston Dynamics)losing toGR00T adopted by rivals since 2025 while EFORT's Openmind models show no confirmed shipments as of Jun 2026
Questions people ask
Is EFORT Intelligent Equipment profitable in 2026?
No. EFORT posted a net loss of roughly CNY 439.52m on a trailing-twelve-month basis as of July 9, 2026, with a net profit margin of -15.9% reported in August 2025. Revenue also fell from CNY 1.89bn in 2023 to CNY 932.13m in 2025, a two-year collapse of about 50%.
Is EFORT losing to Estun Automation?
Yes, on capital and scale. Estun is China's #1 domestic robot brand with ~9.5-10.5% market share and completed a Hong Kong secondary listing in March 2026, raising fresh capital. EFORT remains smaller by revenue and market cap, with FY2025 revenue of just CNY 932.13m versus Estun's ~CNY 4bn in 2024.
Could AI or humanoid robots replace EFORT's business?
EFORT's welding and painting arm business faces pressure from AI-driven humanoid platforms like NVIDIA's Isaac GR00T, adopted by rivals such as Unitree and Boston Dynamics. EFORT's own embodied-AI response, Openmind's R2V1/R2V2/W2 models announced June 2026, has no independently verified commercial shipments yet.
Who owns EFORT Intelligent Equipment?
EFORT is publicly traded on Shanghai's STAR Market (688165.SH) since its July 15, 2020 IPO, with no single controlling shareholder. Top holders include ShenZhen Co-Stone Asset Management (2.63%) and Midea Group (2.62%), with VC and PE funds holding roughly 21.4% of shares as of 2026.
What is EFORT's biggest competitor?
Estun Automation is EFORT's closest domestic rival, holding roughly 9.5-10.5% of China's industrial robot market versus EFORT's smaller share, and raising fresh capital via a March 2026 Hong Kong listing. Global players FANUC (~10.9% China share) and ABB also compete directly in EFORT's core hardware market.
Will the US ban on Chinese humanoid robots hurt EFORT?
Potentially. The US FCC announced a ban on imports of new foreign-made humanoid and quadruped robots on July 29, 2026, targeting Chinese manufacturers. This closes a possible US export path for EFORT's Openmind embodied-robotics subsidiary before its R2V1/R2V2/W2 models have shown any confirmed commercial shipments.
Timeline
  • 2026-07-29US FCC bans imports of foreign-made humanoid and quadruped robots, targeting Chinese makers
  • 2026-06-11Foundation work completed at EFORT's CNY 1.9bn Wuhu robot super-factory, Anhui
  • 2026-03-31Q1 2026 revenue hits CNY 304.13m, up 20.55% YoY after two years of decline
  • 2026-03Rival Estun Automation completes Hong Kong secondary listing (HKEX:2715)
  • 2025-12-31FY2025 revenue falls to CNY 932.13m, down 32.1% YoY
  • 2024-12-31FY2024 revenue falls to CNY 1.373bn, down 27.2% YoY
  • 2020-07-15EFORT IPOs on Shanghai STAR Market under ticker 688165.SH
Revision history
30 July 2026
First assessed. Little protection left. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources